IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Synthesis of New Thiocarbamates and Evaluation of their Cholinesterase Inhibitory Effect

Author: BAHAREH VAYEGHAN
Abstract: Alzheimer's disease is a neurodegenerative disorder in which cholinergic neurons destroy specific parts of the brain and decrease acetylcholine levels. Therefore, enhancing cholinergic function, which increases acetylcholine levels in the brain, has been proposed as a perspective for symptomatic treatment of Alzheimer's disease. For this reason, cholinesterase inhibitors are one of the most commonly used drugs for Alzheimer's patients today. In this study, we are investigating the availability of novel compounds of cholinesterase inhibitors. After reviewing the results of previous studies, a number of compounds were suggested and synthesized as acetylcholinesterase inhibitors. Two final products called 3- (2 and 6-dichlorophenyl) -3-oxo-1-phenylpropyl 2-chlorobenzene carbamodiodioate and1- (4- chlorophyll) -3-phenylpropyl hydroxylcarbamodiodioate were synthesized as Cholinesterase inhibitors. To synthesize each of these two products, two intermediates were first provided and these inhibitors were prepared from their reaction. In the next step, by using docking studies and computational methods, the intensity and type of interaction of the designed molecules and the enzyme were estimated and finally synthesized for these compounds, with the addition of the intermediate compound 1 The structure of intermediate compound 2 and the final compound were confirmed by spectroscopy. The new compound is obtained. Then, a quantitative study was performed on the structure-activity relationship of a batch of compounds and a model was presented to estimate their cholinesterase activity
Keyword: Alzheimer's Disease, Acetylcholinesterase Inhibitors of Acetylcholinesterase, Molecular Docking, QSAR
DOI: https://doi.org/10.31838/ijpr/2020.12.01.027
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free